PSAP and Parkinson disease: By analyzing leukocytes from 42 patients with PD and 37 healthy controls, they found that GCase and β-galactosidase activities were reduced by 20% in patients with PD compared to controls, whereas PSAP and Sap C protein levels were significantly reduced and correlated with increased α-Syn levels in patients with PD.